Risk of Psychosis With Stimulants in ADHD Patients
The Carlat Child Psychiatry Report, Volume 10, Number 4&5, May 2019
Jess Levy, MD.
Dr. Levy has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
As of 2007, the FDA requires stimulant manufacturers to warn of possible psychosis with stimulant use. This article analyzes the results of a 2019 study comparing the risk of psychosis between methylphenidate and amphetamine classes of medications.